Skip to Main Content

Paper Details

Circulating Growth Differentiation Factors 11 and 8, Their Antagonists Follistatin and Follistatin-Like-3, and Risk of Heart Failure in Elders.
J Gerontol A Biol Sci Med Sci
1
2024
FLST-3, FSTL-3, Follistatin, Follistatin-like-3, GDF-11, GDF-8, Growth Differentiation Factors 11 and 8, HF, Heart Failure, follistatin, follistatin-like (FSTL)-3, growth differentiation factor (GDF)-11, heart failure, men, participants, serum follistatin, transforming, transforming growth factor-superfamily
Author NameAffiliation
Jorge R Kizer
Jorge R KizerUniversity of California San Francisco
Shalender BhasinBrigham and Women's Hospital, Harvard Medical School
Peggy M CawthonUniversity of California San Francisco
Peggy M CawthonResearch Institute, California Pacific Medical Center
Bruce M PsatyCardiovascular Health Research Unit, University of Washington
Russell P TracyUniversity of Vermont Larner College of Medicine
  • 1 - 7

Datasets

Release 1.2